We are committed to fueling the next wave of biotech innovation in the Midwest. By investing in early-stage life science startups, we provide the capital, mentorship, and connections needed to turn br ...

MIF is the philanthropic fund of the Multiple Myeloma Research Foundation, investing in companies developing therapeutic platforms and targets for the benefit of myeloma patients.

N-Zyme Biomedical has identified a novel, causal mechanism of disease in reflux (LPR/GERD), owns the mechanism with its IP portfolio, and is rapidly developing clinical-stage assets. With near-term Ph ...

Nasus Pharma vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intr ...

The NSCEB is a legislative commission advising Congress on policies at the intersection of emerging biotechnology and national security.

Nob Hill Therapeutics, Inc. (NHT) is developing new therapies for lung-related diseases that cannot be effectively treated today.  

We are a research-driven investment bank focused on small cap emerging growth companies in the healthcare, technology, media and natural resources sectors.

NÖK Therapeutics, Inc. is a clinical-stage biotechnology innovator redefining the next generation of cancer immunotherapy by harnessing the innate power of natural killer (NK) cells. The company is fo ...

We are the policy and advocacy organization for the NC Life Sciences industry.

On behalf of our parent company, Nippon Shinyaku Co., Ltd, we are seeking in-licensing opportunities in the therapeutic areas of Hematology, Orphan diseases and external innovation opportunities in th ...